Prasol Chemicals will launch its Rs 500-crore Initial Public Offering on September 8. The company has fixed the price band at Rs 643-676 pe...

Trying to time the market turns volatility into something that beats an investor twice: Once on the way down, and once on the way up. So, i...

Permira, a leading global private equity firm, is ready to buy a significant stake in Cloudnine Hospitals, which places the parent company'...

Aurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...

Another worry has emerged for the markets, and it will drive the narrative in the short term. As usual, it comes from the US. The US Fed ha...

When the Indian market will start to recover in any real sense is still an open question. But one positive is that the broader market indic...

Aster DM Quality Care is negotiating to acquire a controlling stake in Yatharth Hospitals. This potential acquisition aims to consolidate t...

Given the possibility of hostilities resuming in the Gulf region, focus on risk management in the market. Why? Because fresh hostilities wi...

The ratings agency said mergers and acquisitions are evolving from an occasional growth option into a core strategic tool for companies see...

Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...

Shell is reportedly seeking to sell its U.S. chemical assets for up to eight billion dollars. Several major companies and a private equity ...

Symbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical ...

India Private Equity Investment 2026: Geopolitical risks now shape private equity deal considerations in India. Investors increasingly focu...

Market breadth is important, especially at this point of time. It is a better indicator of both underlying sentiment and what is likely in ...

Foreign investors sold nearly Rs 1 lakh crore from ten Indian stocks. Eight of these companies saw their stock prices increase despite the ...

On Tuesday, Indian stock markets experienced a downturn influenced by increasing oil prices and escalating tensions in the Middle East. Nev...

Will be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.